Since January 2021, Kaewta joined Baiya Phytopharm as R&D manager to oversee the introduction of newly created products using Baiya Phytopharm’ s plant-based technology. She embraces her love for laboratory work as she discovered her interest in genetics and biotechnology throughout her academic years. While producing various proteins for further research, her other goal is to produce future researchers and scientists who are able to push the scientific field forward.

Achievement: Kaewta has successfully developed more than 100 constructs of new recombinant molecular proteins in biologics using the BaiyaPharming™ technology platform through continuous R&D. These advancements can lead to clinical trials and marketing. Her project highlights include Baiya SARSCoV-2, Growth Factor, Secretory IgA, Cytokine, and Cytokine-Receptor, cancer constructs such as Anti-PD1 and Anti-PDL1, Anti-fungi, Anti-IgE, and many others.

Kaewta Rattanapisit, Ph.D.
Research & Development Manager

Since January 2021, Kaewta joined Baiya Phytopharm as R&D manager to oversee the introduction of newly created products using Baiya Phytopharm’ s plant-based technology. She embraces her love for laboratory work as she discovered her interest in genetics and biotechnology throughout her academic years. While producing various proteins for further research, her other goal is to produce future researchers and scientists who are able to push the scientific field forward.

Achievement: Kaewta has successfully developed more than 100 constructs of new recombinant molecular proteins in biologics using the BaiyaPharming™ technology platform through continuous R&D. These advancements can lead to clinical trials and marketing. Her project highlights include Baiya SARSCoV-2, Growth Factor, Secretory IgA, Cytokine, and Cytokine-Receptor, cancer constructs such as Anti-PD1 and Anti-PDL1, Anti-fungi, Anti-IgE, and many others.